相关实验视频
Updated: May 16, 2025

08:03
In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
2.3K
在长期的脊椎手术中首次使用塞福洛キシ姆的目标组织度:在重量按剂量重复使用后的持续评估
Magnus Andreas Hvistendahl1,2, Mats Bue1,2,3, Pelle Hanberg1,2
1Aarhus Denmark Microdialysis Research, Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus N, Denmark.
British journal of clinical pharmacology
|April 1, 2025
概括
这项研究发现,在长脊椎手术期间,重复服用 cefuroxime 有效地保持了目标组织度高于金黄色葡萄球菌的最小抑制度. 这确保了适当的抗微生物预防,以预防术后感染.
科学领域:
- 手术感染预防 手术感染预防
- 脊柱外科手术中的药理动力学
- 抗微生物预防 优化 优化
背景情况:
- 手术后的脊柱感染是一个重大问题,需要有效的抗微生物预防.
- 目前对黄素的剂量策略缺乏关于目标组织度的可靠临床数据.
- 在复杂的脊椎手术中,优化素的输送对于预防手术部位感染至关重要.
研究的目的:
- 在长期的脊椎手术期间,持续评估外科和术后的塞福洛キシ姆组织度.
- 确定各种组织中黄金葡萄球菌 (4微克/毫升) 的最小抑制度 (MIC) 以上的时间.
- 评估按重量剂量测量黄素在脊椎手术患者中达到治疗度的疗效.
主要方法:
- 招募了20名接受脊柱形手术的患者,接受了低血压麻醉.
- 静脉注射塞福洛キシ姆 (20 mg/kg) 进行了手术前和手术后4小时的治疗.
- 微透析探针对脊椎骨,肌肉,皮下组织和伤口部位的塞福洛キシ姆度进行了长达12小时的抽样.
主要成果:
- 在所有测量的组织和血中,在整个手术持续时间内,Cefuroxime在MIC (fT>MIC4) 上实现了100%的时间.
- 在第一个剂量间隔期间,骨,肌肉和皮下组织中, cefuroxime fT>MIC4的中位数为93%.
- 第二次剂量间隔显示了持续的塞福洛キシ姆fT>MIC4,从血中的70%到表面伤口组织中的100%.
结论:
- 重复重量注射的素 (20 mg/kg) 确保了均且足够的手术内组织暴露 (100% fT>MIC4).
- 这种剂量方案为5.5-7.5小时提供足够的手术后 cefuroxime 度 (>4μg/mL).
- 这些发现支持在长脊椎手术中使用这种基于体重的 cefuroxime 疗法进行有效的抗微生物预防.
相关概念视频
Local Anesthetics: Clinical Application as Spinal Anesthesia
561
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
561
Drug Delivery: Parenteral Route
341
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
341

